April 23rd 2024
Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
23rd Annual International Congress on the Future of Breast Cancer® East
July 19-20, 2024
Register Now!
Expert Illustrations & Commentaries™: Targeting Immune Cells to Treat Multiple Sclerosis
View More
15th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 11, 2024
View More
Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies
View More
4th Annual International Congress on the Future of Women’s Health™
View More
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
Juneteenth: Celebrating Black women in obstetrics and gynecology
June 19th 2020June 19, 1865, also known as Juneteenth, celebrates the end of slavery in the United States. On this day nearly 160 years ago, Union troops arrived in Galveston, TX to announce the end of the Civil War and the emancipation of slavery in the United States.
Read More
The Society for Maternal-Fetal Medicine consult series #49 on cesarean scar pregnancy
Cesarean scar pregnancy (CSP) is a complication in which an early pregnancy implants in the scar from a prior cesarean delivery. Incidence and recognition of this condition appear to have increased over the past two decades, perhaps due to high worldwide cesarean delivery rates. The clinical presentation is variable, and many women are asymptomatic at presentation. CSP can be difficult to diagnose in a timely fashion. Ultrasound is the primary imaging modality for CSP diagnosis. Expectantly managed CSP is associated with high rates of severe maternal morbidity such as hemorrhage, placenta accreta spectrum (PAS), and uterine rupture. Given these substantial risks, pregnancy termination is recommended after CSP diagnosis. Several surgical and medical treatments have been described for this disorder, but at this time, optimal management remains uncertain.
Read More
Video Series: Dr. Dotters-Katz weighs in on COVID-19 in pregnancy
May 5th 2020Dr. Sarah Dotters-Katz is a maternal-fetal medicine specialist and obstetrician and gynecologist at Duke Health in Durham, N.C. One of her research interests is clinical infectious diseases and how they impact pregnancy.
Watch
New study contradicts earlier findings about ondansetron teratogenicity
November 26th 2019Although prior research indicated that intravenous (IV) ondansetron in pregnancy could increase risk for congenital malformations, a follow-up study, recently published in JAMA Psychiatry, has refuted those findings.
Read More